AaviGen
PrivateLast Round
Accelerator
Jun 4, 2025
Total Funding Raised
$18.85M
Company Overview
AaviGen is a biotechnology company that develops precision gene therapies for cardiovascular and cardiopulmonary diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AaviGen Comps
Public and private peers based on sector, stage, and business model.
AaviGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 4, 2025 | ||||
| Series B | Jul 26, 2023 |
AaviGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| dievini Hopp BioTech holding | Series B |
| German Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2025
Received funding from German Accelerator.
- Jul 26, 2023
$19M round led by DH-LT Investments GmbH.
AaviGen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AaviGen's valuation, stock price, and market status.
